The global dental insurance market is projected to grow from USD 118.77 billion in 2026 to USD 198.31 billion by 2032, with a CAGR of 8.72%. Growth is driven by digital transformation, evolving care models, and regulatory shifts. Key trends include provider consolidation, value-based care models, and increased investment in analytics and digital-first distribution channels.
Humana Inc. (HUM)
Common Stock · Currency in USD · XNYS
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Company Info
SIC6324
Composite FIGIBBG000BLKK03
CIK0000049071
IPOMay 18, 1971
Sectorhospital & medical service plans
Highlights
Market Cap$21.35B
EPS$6.48
P/E Ratio27.51
Revenue$130.07B
Gross Profit$130.60B
Net Income$776.00M
Employees67,060
WSO120,054,462
Phone(502) 580-1000
Websitehttps://www.humana.com
Related Tickers
Analysis
Share Price Chart
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Humana Inc., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Returns By Period
Humana Inc. (HUM) has returned -30.55% so far this year and -28.10% over the past 12 months. Looking at the last ten years, HUM has achieved an annualized return of -0.39%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
HUM
1M-1.87%
6M-37.47%
YTD-30.55%
1Y-28.10%
5Y-15.73%
10Y-0.39%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of Humana Inc. (HUM) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -23.76% | 0.92% | -7.98% | 2.48% | ||||||||
| 2025 | 14.12% | -7.15% | -2.26% | -1.07% | -11.76% | 5.23% | 3.33% | 21.70% | -14.58% | 7.01% | -11.59% | 4.12% |
| 2024 | -17.77% | -6.60% | -0.97% | -12.69% | 19.57% | 4.85% | -3.17% | -1.88% | -10.78% | -18.15% | 14.40% | -14.29% |
| 2023 | 0.68% | -2.19% | -1.30% | 6.08% | -5.53% | -11.10% | 2.89% | 0.74% | 4.85% | 7.70% | -3.09% | -5.22% |
| 2022 | -14.93% | 9.95% | 1.02% | 1.81% | 1.53% | 2.70% | 3.28% | -0.05% | 0.79% | 14.68% | -1.01% | -7.23% |
| 2021 | -8.31% | -1.67% | 9.90% | 6.34% | -2.20% | 1.11% | -3.83% | -4.83% | -4.01% | 18.41% | -9.80% | 9.61% |
| 2020 | -8.42% | -5.74% | -2.33% | 27.27% | 9.93% | -4.94% | 1.02% | 5.05% | 0.18% | -4.00% | -0.86% | 1.30% |
| 2019 | 9.06% | -6.91% | -7.24% | -4.80% | -2.09% | 4.08% | 11.22% | -5.12% | -9.49% | 14.94% | 15.47% | 7.05% |
| 2018 | 13.02% | -3.54% | -1.03% | 4.30% | -1.08% | 1.84% | 5.82% | 5.92% | 1.51% | -5.80% | 2.41% | -13.26% |
| 2017 | -2.15% | 6.38% | -2.76% | 7.40% | 4.53% | 3.64% | -4.41% | 11.22% | -5.56% | 4.48% | 1.80% | -4.88% |
| 2016 | -3.12% | -3.08% | 4.42% | -4.39% | 3.30% | -1.31% | -3.03% | 23.63% | -3.73% |
Performance Indicators
The charts below present risk-adjusted performance metrics for Humana Inc. (HUM) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of HUM compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current Humana Inc. volatility is 2.09%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 48.91B | 46.48B | 47.07B | 43.06B | 44.36B | 34.97B | 29.07B | 25.41B | 27.18B | 25.40B | 24.71B | 23.47B | 20.74B | 19.98B | 17.71B | 14.15B |
| Equity Attributable To Parent (USD) | 17.66B | 16.38B | 16.26B | 15.31B | 16.08B | 13.73B | 12.04B | 10.16B | 9.84B | 10.69B | 10.35B | 9.65B | 9.32B | 8.85B | 8.06B | 5.78B |
| Equity Attributable To Noncontrolling Interest (USD) | 80.00M | 70.00M | 56.00M | 59.00M | 23.00M | - | - | - | - | - | - | - | - | - | - | - |
| Equity (USD) | 17.74B | 16.45B | 16.32B | 15.37B | 16.10B | 13.73B | 12.04B | 10.16B | 9.84B | 10.69B | 10.35B | 9.65B | 9.32B | 8.85B | 8.06B | 5.78B |
| Other Non-current Liabilities (USD) | - | - | - | - | - | - | - | - | - | - | - | - | 2.50B | 2.15B | 1.93B | - |
| Long-term Debt (USD) | - | - | - | - | - | - | - | - | - | - | - | - | 2.60B | 2.61B | 1.66B | - |
| Noncurrent Liabilities (USD) | 14.83B | 13.10B | 11.88B | 10.51B | 12.92B | 7.85B | 6.11B | 5.18B | 7.93B | 6.89B | 6.21B | 6.47B | 5.10B | 4.76B | 3.59B | 3.12B |
| Current Liabilities (USD) | 16.35B | 16.94B | 18.87B | 17.18B | 15.33B | 13.39B | 10.93B | 10.08B | 9.41B | 7.82B | 8.15B | 7.36B | 6.32B | 6.38B | 6.06B | 5.26B |
| Liabilities (USD) | 31.17B | 30.03B | 30.75B | 27.69B | 28.26B | 21.24B | 17.04B | 15.25B | 17.34B | 14.71B | 14.36B | 13.82B | 11.42B | 11.13B | 9.65B | 8.38B |
| Other Non-current Assets (USD) | 12.82B | 12.69B | 12.36B | 11.89B | 13.75B | 8.96B | 7.23B | 6.49B | 7.97B | 7.42B | 7.25B | 6.76B | 6.52B | 6.44B | 5.18B | 4.22B |
| Intangible Assets (USD) | 1.13B | 1.44B | 1.69B | 1.77B | 2.64B | - | - | 245.00M | 226.00M | 280.00M | 357.00M | 572.00M | 693.00M | 731.00M | 435.00M | - |
| Fixed Assets (USD) | 2.23B | 2.53B | 3.03B | 3.22B | 3.07B | 2.37B | 1.96B | 1.74B | 1.58B | 1.51B | 1.38B | 1.42B | 1.22B | 1.10B | 912.00M | 679.14M |
| Noncurrent Assets (USD) | 16.18B | 16.66B | 17.08B | 16.87B | 19.47B | 11.33B | 9.19B | 8.47B | 9.78B | 9.21B | 8.99B | 8.75B | 8.44B | 8.27B | 6.53B | 4.90B |
| Other Current Assets (USD) | 29.46B | 27.11B | 27.95B | 24.51B | 23.08B | 22.50B | 18.83B | 15.93B | 16.55B | 14.91B | 14.55B | 13.54B | 11.35B | 10.98B | 10.15B | - |
| Accounts Receivable (USD) | 3.27B | 2.70B | 2.04B | 1.67B | 1.81B | 1.14B | 1.06B | 1.02B | 854.00M | 1.28B | 1.16B | 1.17B | 950.00M | 733.00M | 1.03B | - |
| Current Assets (USD) | 32.73B | 29.82B | 29.99B | 26.18B | 24.89B | 23.64B | 19.89B | 16.95B | 17.40B | 16.19B | 15.71B | 14.71B | 12.30B | 11.71B | 11.18B | 9.25B |
| Assets (USD) | 48.91B | 46.48B | 47.07B | 43.06B | 44.36B | 34.97B | 29.07B | 25.41B | 27.18B | 25.40B | 24.71B | 23.47B | 20.74B | 19.98B | 17.71B | 14.15B |
News and Insights
DAV (Disabled American Veterans) announced the continuation of its partnership with Humana for the sixth consecutive year. Humana will expand its investment in DAV's mission to support veterans and their families by addressing challenges such as hunger, homelessness, financial strain, and transportation barriers. DAV assists over 1 million veterans annually in accessing benefits including health care, disability compensation, and employment resources.
Lifeward announced that Aetna has approved Medicare Advantage coverage for its ReWalk Personal Exoskeleton, joining Humana and UnitedHealthcare. The three insurers collectively represent approximately 16 million beneficiaries, significantly expanding access to the FDA-approved exoskeleton technology for individuals with spinal cord injuries.
Major M&A activity includes Mercedes-Benz planning to sell part of its Daimler Truck stake for €12 billion, Humana in advanced talks to acquire MaxHealth for ~$1 billion, ByteDance selling Mobile Legends creator for $6-7 billion, and Britney Spears selling her music catalog to Primary Wave. Warner Bros. Discovery faces activist opposition to its Netflix deal, while Baker Hughes considers divesting Waygate Technologies.
Humana stock fell to a 52-week low after the health insurer issued weak fiscal 2026 guidance, with adjusted EPS expected at $9 versus Wall Street's estimate of $11.92. While the company beat Q4 revenue expectations at $32.64 billion and reported solid operational performance, the significant earnings miss and membership declines overshadowed the positive results.
T-Mobile exceeded Q4 2025 earnings expectations with EPS of $2.14 and revenue of $24.33 billion, driven by industry-leading customer growth and network quality. The company projects 10% core adjusted EBITDA growth and $18.0-18.7 billion in adjusted free cash flow for 2026. Kraft Heinz faced sales decline but beat EPS expectations, while Humana exceeded revenue and EPS projections with strong Medicare Advantage growth.
Ten large-cap stocks experienced significant declines during the week of January 26-30, 2026. Unity Software fell 31.63% following CEO comments about world models amid competition from Google's Project Genie. Precious metals stocks including Hecla Mining (down 33.33%) and Coeur Mining (down 26.13%) declined after President Trump's nomination of Kevin Warsh for Fed Chair strengthened the dollar. Healthcare stocks UnitedHealth (down 17.87%) and Humana (down 26.07%) fell after analyst downgrades. Other notable losers included The Trade Desk (down 16.61%), First Majestic Silver (down 22.86%), Axon Enterprise (down 20.88%), Reddit (down 16.79%), and Regencell Bioscience (down 13.38%).
Michael Burry, famous for betting against the housing market, liquidated his UnitedHealth stake in Q3 2025 and rotated heavily into Molina Healthcare, calling it a 'generational buy.' While major insurers faced steep losses following a low 2027 Medicare rate proposal from CMS, Molina fared better than peers due to its 75% Medicaid revenue exposure and disciplined operations. Burry's contrarian bet appears to be paying off early in 2026.
Humana shares plummeted 13.49% in premarket trading following the Trump administration's proposal for nearly flat Medicare Advantage payment rates for 2027, with only a 0.09% net average payment increase versus Wall Street expectations of 4-6%. The broader health insurance sector also suffered significant losses, with CVS Health, UnitedHealth Group, and Elevance Health all declining sharply.
The Centers for Medicare & Medicaid Services (CMS) proposed a 2027 Medicare Advantage payment increase of only 0.09%, significantly below Wall Street's expectations of 4-6%. This modest growth announcement triggered sharp declines in major health insurer stocks, with UnitedHealth, Humana, and CVS Health leading the losses. The CMS emphasized program sustainability and payment accuracy through updated risk adjustment models.